Robert Cook

Robert Cook is an experienced pharmaceutical executive currently serving as the Head of Generics and Senior Vice President of Global Small Molecule CMC & Combination Products at Teva Pharmaceuticals since July 2013. With a robust background in R&D leadership, Robert has advanced generic and specialty branded products, focusing on drug-device combinations, semisolids, and inhalation therapies. Prior roles include Senior Director of Product Commercialization at MicroDose Therapeutx, where Robert facilitated a corporate transition and led key product initiatives, and Director of Research and Development at MAP Pharmaceuticals, overseeing critical development projects. Robert's career began as a Clinical Pharmacist at The London Clinic and a Pre-Registration Pharmacist at AstraZeneca, bolstered by a Ph.D. in Pharmaceutics from the University of London and a BPharm from the University of Nottingham.